Agreement Value:
$49,000,000.00
Agreement Date:
Jun 9, 2023 - Mar 31, 2037
Description:
This project will establishment the Open Science Drug Discovery network, an open science ecosystem leveraging artificial intelligence (AI) towards new potential drug and therapeutics discovery particularly for antimicrobial resistance, pandemic preparedness and rare diseases.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
The investment will enhance drug discovery through artificial intelligence (AI)-based research to more rapidly invent new medicines in areas of market failure, mainly antimicrobial resistance (AMR), pandemic preparedness and rare diseases.
Location:
Toronto, Ontario, CA M5G1L7
Reference Number:
033-2023-2024-Q1-816034
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
736784737
Recipient Type:
Not-for-profit organization or charity
Additional Information:
The end date was updated from 31/03/2036 to 31/03/2037 to provides for a 12 month extension. It now reflects the entirety of the agreement duration, including the benefit phase and residual audit period.
Amendment Date
Nov 26, 2025
Recipient's Operating Name:
Conscience Medicines Network
Recipient's Legal Name:
Conscience Medicines Network
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Stream 5 National Innovation Ecosystems
Program Purpose:
The Strategic Innovation Fund (SIF) attracts and supports new high-quality business investments. In allocating funding, SIF looks to accelerate areas of economic strength, strengthen and expand the role of Canadian firms in regional and global supply chains, support economic strategies, and attract investment that creates new, good, well-paying jobs.